Does the Medline mega-deal herald the return of giant buyouts?

Listen to this story

Your browser does not support the <audio> element.

BUYOUT SHOPS are neck-deep in dry powder. Earlier this year the world’s private-equity firms were sitting on $1.9trn in unspent capital. This month three of the biggest, Blackstone, Carlyle and Hellman & Friedman, reportedly agreed to pay $34bn for control of Medline, a supplier of medical equipment. It will be the biggest leveraged buyout since the global financial crisis of 2007-09 put paid to most such debt-fuelled acquisitions.

This article appeared in the Business section of the print edition under the headline “Dealing with abundance”

→ Continue reading at The Economist

Similar Articles


Most Popular

Loki’s first two episodes are a blast

When Loki is first captured by an organization devoted to maintaining the purity...

ViacomCBS, Discovery Face Showdown in TV’s Upfront Ad Talks (EXCLUSIVE)

This year’s upfront ad-sales session is shaping up to be one of the fastest in recent memory. But some TV companies are working to...

Tensions build over who is responsible for Bitter Lake homeless encampment on school grounds

The homeless encampment near Broadview Thomson K-8 is drawing attention from more Seattle mayoral candidates who say the city needs to step in. ...